Isosorbide Mononitrate Extended-Release Tablets work by dilating peripheral blood vessels and promoting redistribution of myocardial blood flow. Patients should use the medication as prescribed.
Isosorbide mononitrate extended-release tablets is a kind of vasodilator, through the dilation of peripheral blood vessels to reduce the cardiac load, so that the myocardial oxygen consumption decreased, but also to promote the redistribution of myocardial blood flow, so that the ischemic area of the blood supply has been improved, to play the role of anti-myocardial ischemia.
Clinically, isosorbide mononitrate extended-release tablets are mainly used for the prevention of angina pectoris, long-term treatment of coronary heart disease and the treatment of persistent angina pectoris after myocardial infarction, and can also be used in combination with diuretics or/and digitalis for the treatment of chronic congestive heart failure.
It should be noted that the use of isosorbide mononitrate extended-release tablets is prohibited for those who are allergic to any of the components of this drug, as well as patients with marked hypotension, acute circulatory failure, cardiogenic shock, increased intracranial pressure, severe anemia, glaucoma, acute myocardial infarction, hypertrophic obstructive heart disease, and avoiding the use of sildenafil during the administration of the drug.
Some patients may experience headache, nausea, vomiting, flushing, excessive sweating, tachycardia, exfoliative dermatitis and other adverse reactions during the use of the drug, if the discomfort is more serious symptoms should be timely medical treatment.
Patients should follow the doctor’s instructions to take isosorbide mononitrate extended-release tablets, not blindly use their own medication, so as not to affect the condition.